Duke Street Bio granted approval by European Medicines Agency to launch next-generation PARP1-selective inhibitor trial
September 24, 2024

September 24, 2024
September 18, 2024
August 12, 2024
July 23, 2024
July 22, 2024
July 16, 2024
June 26, 2024
June 12, 2024
June 11, 2024
April 2, 2026
The partnership pairs Pillar’s portfolio of oncoReveal® kitted NGS panels with CellCarta’s global laboratory network and biomarker expertise to reduce...
April 2, 2026
Plasmidsaurus, the leading Sequencing as a Service company, has announced two transformative evolutions of its RNA-Seq ecosystem: the launch of a high...
March 26, 2026
New media development services designed to optimize cell culture media development and identify robust, scalable media formulations driving cell cultu...

Life Science Newswire is a division of BioStrata Ltd, with company registered address: 3rd Floor, 1 Ashley Road, Altrincham, Cheshire, England, WA14 2DT. Company registration number: 8233225